🇺🇸 FDA
Patent

US 11504402

Compositions comprising bacterially derived minicells and methods of using the same

granted A61KA61K31/337A61K31/4745

Quick answer

US patent 11504402 (Compositions comprising bacterially derived minicells and methods of using the same) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
EnGeneIC Molecular Delivery Pty Ltd
Grant date
Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/337, A61K31/4745, A61K31/505, A61K31/517